Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.
Clear Labs announced its expanded automation platform and collaboration with Labcorp to develop streamlined, oncology-focused NGS workflows, marking its move beyond infectious disease sequencing and ...
Simple, Accurate, Affordable Solution for Pharmacogenomics Profiling to Identify Genetic Biomarkers Associated with Drug Response-- --Learn ...
Agilent Technologies introduced SureSelect Human All-Exon V5 and V5 + UTRs for next-generation sequencing. The new all-exon solutions incorporate the latest advances from Agilent Genomics, the ...
Zacks Investment Research on MSN
TEM Continues to Strengthen Its Genomics Leadership With New Products
Tempus AI TEM has been putting in efforts to solidify its position in the genomics space. In September 2025, the company received FDA 510(k) clearance for its xR IVD to support life sciences drug ...
Clinical Trials Arena on MSN
Sophia Genetics and Element partner to advance precision medicine research
The companies’ aim to unite their respective technologies to create an end-to-end workflow for precision medicine research in lab settings.
The server room for the Food and Drug Administration’s “Hive” literally buzzes with activity as it harnesses massive amounts of computing power to analyze detailed information on DNA and RNA sequences ...
SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology ...
Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...
BACKGROUND: Bacterial surface display libraries are a popular tool for novel ligand discovery due to their ease of manipulation and rapid growth rates. These libraries typically express a scaffold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback